Global Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5887689

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Hemoglobin Testing Market size was estimated at USD 5.70 billion in 2023, USD 6.04 billion in 2024, and is expected to grow at a CAGR of 6.10% to reach USD 8.63 billion by 2030.The hemoglobin testing market comprises various diagnostic products, services, and technologies that healthcare professionals utilize to evaluate patients' hemoglobin levels. Accurate assessment of hemoglobin concentration is essential for diagnosing anemia, thalassemia, sickle cell disease, and other related medical conditions. The market includes spectrophotometers, chromatographic systems, point-of-care devices, reagents, consumables, and clinical laboratory services. The rising prevalence of anemia worldwide due to iron deficiencies and growing incidences of chronic diseases such as diabetes and kidney disorders significantly contribute to market growth. Also, heightened awareness about preventive healthcare and early diagnosis has increased adoption rates in developed and developing countries. Technological advancements have introduced more efficient testing methodologies such as automated analyzers, immunoassays, and bioinformatics platforms. Personalized medicine offers potential growth opportunities by providing precision diagnosis and targeted therapies based on individual genetic makeup. However, challenges exist within the hemoglobin testing market about the high costs associated with advanced diagnostic devices hindering adoption rates in resource-constrained settings; stringent regulatory guidelines may impede timely commercialization of innovative technologies; limited awareness about early diagnosis restricts market penetration; harmonizing international standards for consistent measurement remains crucial.

Regional Insights

In the Americas region, the United States & Canada, raising awareness of diabetes complications and riding government investment in healthcare research and innovative medical technologies such as diabetic retinopathy and high adoption of advanced technologies contribute to market expansion. European Union countries have observed substantial growth in hemoglobin testing owing to high rates of obesity, diabetes, and cardiovascular diseases. EU-funded projects such as Horizon 2020 and Innovative Medicines Initiative promote advancements in hematology diagnostics and foster collaborations among academic institutions, research centers, and industry partners. The Middle East and Africa focus on enhancing healthcare infrastructure while addressing a rising prevalence of blood disorders, including sickle cell disease and thalassemia. Investments from global organizations such as the World Health Organization (WHO) support early diagnosis and management through routine hemoglobin testing. In the APAC region, the major countries China, Japan, and the Indian government are taking initiatives to meet the demand for hemoglobin testing due to high population density and health concerns such as anemia among pregnant women fuel strong demand for hemoglobin tests.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemoglobin Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemoglobin Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, ACON Laboratories, Inc., AdvaCare Pharma, Arkray, Inc., ARUP Laboratories, Attikouris Enterprises Ltd., Avantor, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Boditech Med Inc., Clarity Diagnostics, LLC, Cliawaived, Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC by IBL PLC, F. Hoffmann-La Roche AG, HemoCue AB, Laboratory Corporation of America Holdings, Masimo Corp., Merck KGaA, Nova Biomedical, OrSense Ltd., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Sotera Health Company, Thermo Fisher Scientific Inc., Versiti, Inc., and VivaChek Biotech (Hangzhou) Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Blood Glucose Testing
- Cyanmethemoglobin Method
- Hemoglobin Electrophoresis
Technology
- Laboratory Testing
- Point-of-Care Testing
Operation
- Invasive Testing
  - Invasive Cuvette
  - Invasive Strip
- Non-Invasive Testing
Application
- Anemia Diagnosis & Monitoring
- Diabetes Diagnosis & Management
- Sickle Cell Disease Screening
- Thalassemia Detection
End-User
- Blood Bank
- Diagnostic Laboratories
- Homecare Settings
- Hospitals & Clinics
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Hemoglobin Testing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemoglobin Testing Market?
What are the technology trends and regulatory frameworks in the Hemoglobin Testing Market?
What is the market share of the leading vendors in the Hemoglobin Testing Market?
Which modes and strategic moves are suitable for entering the Hemoglobin Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Hemoglobin Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and need for regular hemoglobin level monitoring
5.1.1.2. Availability of improved and user-friendly point-of-care testing
5.1.1.3. Government initiatives promoting awareness about anemia testing
5.1.2. Restraints
5.1.2.1. Complexity of certain testing methods and need for specialized skills
5.1.3. Opportunities
5.1.3.1. Technological advancements in hemoglobin testing methods
5.1.3.2. Introduction of high-performing home hemoglobin testing kits and devices
5.1.4. Challenges
5.1.4.1. Concerns associated with inaccuracy and false positives
5.2. Market Segmentation Analysis
5.2.1. Type: Use of cyanmethemoglobin method as a standard and cost-effective technique for measuring total hemoglobin concentration
5.2.2. Operation: Preference for non-invasive hemoglobin testing due to their convenience and ability to reduce discomfort associated with blood draws
5.2.3. Application: Advanced hemoglobin testing solutions to determine the severity of anemia
5.2.4. End-User: Availability of diverse range of hemoglobin testing to diagnose various hematological disorders
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Hemoglobin Testing Market, by Type

6.1. Introduction
6.2. Blood Glucose Testing
6.3. Cyanmethemoglobin Method
6.4. Hemoglobin Electrophoresis

7. Hemoglobin Testing Market, by Technology

7.1. Introduction
7.2. Laboratory Testing
7.3. Point-of-Care Testing

8. Hemoglobin Testing Market, by Operation

8.1. Introduction
8.2. Invasive Testing
8.3.1. Invasive Cuvette
8.3.2. Invasive Strip
8.3. Non-Invasive Testing

9. Hemoglobin Testing Market, by Application

9.1. Introduction
9.2. Anemia Diagnosis & Monitoring
9.3. Diabetes Diagnosis & Management
9.4. Sickle Cell Disease Screening
9.5. Thalassemia Detection

10. Hemoglobin Testing Market, by End-User

10.1. Introduction
10.2. Blood Bank
10.3. Diagnostic Laboratories
10.4. Homecare Settings
10.5. Hospitals & Clinics
10.6. Research Institutes

11. Americas Hemoglobin Testing Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Hemoglobin Testing Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Hemoglobin Testing Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. New Product Launch & Enhancement
14.3.1.1. Mylab Introduces Indigenous Point-of-Care Sickle Cell Anaemia Test
14.3.2. Investment & Funding
14.3.2.1. Hemex Health Awarded USD 3 Million Grant to Advance Commercialization of Gazelle Hb Variant Test for the U.S. market
14.3.3. Award, Recognition, & Expansion
14.3.3.1. Sanguina Receives US FDA Clearance for Haemoglobin Test Kit

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Abcam PLC
15.1.2. ACON Laboratories, Inc.
15.1.3. AdvaCare Pharma
15.1.4. Arkray, Inc.
15.1.5. ARUP Laboratories
15.1.6. Attikouris Enterprises Ltd.
15.1.7. Avantor, Inc.
15.1.8. Becton, Dickinson and Company
15.1.9. Bio-Rad Laboratories, Inc.
15.1.10. Bio-Techne Corporation
15.1.11. Boditech Med Inc.
15.1.12. Clarity Diagnostics, LLC
15.1.13. Cliawaived, Inc.
15.1.14. DiaSys Diagnostic Systems GmbH
15.1.15. EKF Diagnostics Holdings PLC by IBL PLC
15.1.16. F. Hoffmann-La Roche AG
15.1.17. HemoCue AB
15.1.18. Laboratory Corporation of America Holdings
15.1.19. Masimo Corp.
15.1.20. Merck KGaA
15.1.21. Nova Biomedical
15.1.22. OrSense Ltd.
15.1.23. PerkinElmer Inc.
15.1.24. Qiagen N.V.
15.1.25. Quest Diagnostics Incorporated
15.1.26. Siemens Healthcare GmbH
15.1.27. Sotera Health Company
15.1.28. Thermo Fisher Scientific Inc.
15.1.29. Versiti, Inc.
15.1.30. VivaChek Biotech (Hangzhou) Co., Ltd.
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
FIGURE 2. HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEMOGLOBIN TESTING MARKET DYNAMICS
FIGURE 7. HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
FIGURE 12. HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD GLUCOSE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HEMOGLOBIN TESTING MARKET SIZE, BY CYANMETHEMOGLOBIN METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HEMOGLOBIN TESTING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 10. HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 13. HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 15. HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE CUVETTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE STRIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. HEMOGLOBIN TESTING MARKET SIZE, BY NON-INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. HEMOGLOBIN TESTING MARKET SIZE, BY ANEMIA DIAGNOSIS & MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. HEMOGLOBIN TESTING MARKET SIZE, BY DIABETES DIAGNOSIS & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. HEMOGLOBIN TESTING MARKET SIZE, BY SICKLE CELL DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. HEMOGLOBIN TESTING MARKET SIZE, BY THALASSEMIA DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. HEMOGLOBIN TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. HEMOGLOBIN TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 52. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 58. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 84. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 89. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 90. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 102. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 138. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 157. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 163. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 169. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 175. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 181. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 193. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 211. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 216. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 217. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 222. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 223. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 247. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 265. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 280. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. HEMOGLOBIN TESTING MARKET LICENSE & PRICING

Companies Mentioned

Abcam PLC
ACON Laboratories, Inc.
AdvaCare Pharma
Arkray, Inc.
ARUP Laboratories
Attikouris Enterprises Ltd.
Avantor, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Boditech Med Inc.
Clarity Diagnostics, LLC
Cliawaived, Inc.
DiaSys Diagnostic Systems GmbH
EKF Diagnostics Holdings PLC by IBL PLC
F. Hoffmann-La Roche AG
HemoCue AB
Laboratory Corporation of America Holdings
Masimo Corp.
Merck KGaA
Nova Biomedical
OrSense Ltd.
PerkinElmer Inc.
Qiagen N.V.
Quest Diagnostics Incorporated
Siemens Healthcare GmbH
Sotera Health Company
Thermo Fisher Scientific Inc.
Versiti, Inc.
VivaChek Biotech (Hangzhou) Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 6.04 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.63 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	30

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Forecast 2024-2030

Global Hemoglobin A1c Analyzer Market by Product (Bench-top Analyzers, Handheld Analyzers, Reagents & Consumables), Technology (Chemical Methods, Separation Methods), Type, Distribution Channel, End User - Forecast 2024-2030

Hemoglobin Testing Global Market Report 2024

Hemoglobin Testing - Global Strategic Business Report

Global Hemoglobin Testing Market Report and Forecast 2024-2032

About the Hemoglobin Testing Market